Muttenz, Switzerland

Parichehr Malherbe

This inventor holds 8 USPTO granted patents and 5 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2008-2011.


% Patents Active = 12.5

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Parichehr Malherbe: Innovator in Orexin Antagonists

Introduction

Parichehr Malherbe is a notable inventor based in Muttenz, Switzerland. She has made significant contributions to the field of pharmacology, particularly in the development of orexin receptor antagonists. With a total of 8 patents to her name, her work is paving the way for new treatments for sleep disorders.

Latest Patents

Malherbe's latest patents include innovative compounds that target orexin pathways. One of her notable inventions is titled "Heterofused piperidines as orexin antagonists." This invention relates to compounds of a specific formula that may be useful in treating disorders associated with orexin pathways, such as sleep disorders. Another significant patent is "Aminoamides as orexin antagonists," which also focuses on compounds that can serve as orexin receptor antagonists, potentially aiding in the treatment of similar disorders.

Career Highlights

Throughout her career, Parichehr Malherbe has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise in drug discovery and development.

Collaborations

Malherbe has collaborated with several professionals in her field, including Raffaello Masciadri and Roger David Norcross. These collaborations have contributed to her innovative research and the advancement of her patents.

Conclusion

Parichehr Malherbe's work in the development of orexin antagonists represents a significant advancement in the treatment of sleep disorders. Her contributions to the field are invaluable, and her patents reflect her dedication to innovation in pharmacology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…